GlassScriptPhysician profile
Yair Rubinstein
NPI 1922054774
$4,990.93
in general payments reported to CMS, 2019-2025
8 companies · $98.98 in 2025
The $98.98 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $420 · 2020: $419 · 2021: $1,652 · 2022: $194 · 2023: $604 · 2024: $1,603 · 2025: $98.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,273 · Food and Beverage: $1,033.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,272.76 |
| Food and Beverage | $1,033.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gotham Surgical Solutions & Devices, INC. | $1,627.98 | 2020-2024 | |
| Arthrex, INC. | $1,441.76 | 2023-2024 | |
| Smith+Nephew, INC. | $736.68 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Zimmer Biomet Holdings, INC. | $534.16 | 2019-2023 | Tapestry |
| Stryker Corporation | $370.41 | 2024-2025 | T2 Alpha, Variax, Pangea |
| Bioventus LLC | $150.00 | 2020 | |
| Glaxosmithkline, LLC. | $95.19 | 2022-2024 | Nucala |
| Henry Schein, INC. | $34.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yair Rubinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.